Results
Jubilant Pharmova Q1 FY27 Consolidated Net Profit ₹564 Crore
Board approved unaudited standalone and consolidated financial results for Q1 FY27 ended June 30, 2026.
Consolidated revenue from operations stood at ₹22,294 million with a net profit of ₹564 million.
